Last reviewed · How we verify
Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| MenACWY Vaccine | menacwy-vaccine | Pfizer | Conjugate vaccine | Meningococcal antigens |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series:
- Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series treatment updates — RSS
- Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series treatment updates — Atom
- Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series treatment updates — JSON
Cite this brief
Drug Landscape (2026). Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/catch-up-vaccination-for-adults-19-through-26-years-of-age-who-have-not-previously-completed-the-series. Accessed 2026-06-10.
Related
- Catch-up vaccination for adults 19 through 26 years of age who have not previously completed the series full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing